CML: new biologic therapies, endpoints and questions.
作者信息
Martin A, Cheson B D
出版信息
Oncology (Williston Park). 1987 Sep;1(7):12-3, 16.
PMID:3152809
Abstract
摘要
相似文献
1
CML: new biologic therapies, endpoints and questions.慢性粒细胞白血病：新的生物疗法、终点指标及问题
Oncology (Williston Park). 1987 Sep;1(7):12-3, 16.
2
Treatment of chronic myelogenous leukemia with interferons: hematologic, cellular, and genetic investigations.干扰素治疗慢性粒细胞白血病：血液学、细胞和遗传学研究。
Haematol Blood Transfus. 1989;32:134-8. doi: 10.1007/978-3-642-74621-5_23.
3
Treatment with natural human interferon alpha of a CML-patient with antibodies to recombinant interferon alpha-2b.用天然人干扰素α治疗一名对重组干扰素α-2b有抗体的慢性粒细胞白血病患者。
Blut. 1988 Nov;57(5):311-5. doi: 10.1007/BF00320360.
4
[The treatment of chronic myeloid leukemia in chronic phase with interferons].[干扰素治疗慢性期慢性髓性白血病]
Pathol Biol (Paris). 1988 Dec;36(10):1179-81.
5
Interferon alpha in the therapy of CML.α干扰素在慢性粒细胞白血病治疗中的应用
Br J Haematol. 1991 Oct;79 Suppl 1:38-41. doi: 10.1111/j.1365-2141.1991.tb08117.x.
6
Combined therapy interferon and chemotherapy in chronic myelogenous leukemia.
Nouv Rev Fr Hematol (1978). 1989;31(2):171-3.
7
Interferon alpha induced and maintained complete remission in chronic granulocytic leukemia in relapse after bone marrow transplantation.α干扰素可诱导并维持慢性粒细胞白血病骨髓移植后复发患者的完全缓解。
Bone Marrow Transplant. 1989 Jan;4(1):127-8.
8
Sequential treatment of Ph-positive chronic myeloid leukemia with interferon gamma and interferon alpha.使用γ干扰素和α干扰素序贯治疗费城染色体阳性慢性髓性白血病。
Haematologica. 1990 Jul-Aug;75(4):334-9.
9
Activity of alpha-interferons in chronic myelogenous leukaemia.α干扰素在慢性粒细胞白血病中的活性
Br J Clin Pract Suppl. 1988 Mar;62:13-5.
10
Long-term follow-up results of alpha interferon therapy in chronic myelogenous leukemia at M. D. Anderson Cancer Center.MD安德森癌症中心慢性粒细胞白血病α干扰素治疗的长期随访结果
Leuk Lymphoma. 1993;11 Suppl 1:169-74. doi: 10.3109/10428199309047881.
Zotero 插件